This pipeline computes the correlation between significant copy number variation (cnv focal) genes and selected clinical features.
Testing the association between copy number variation 63 focal events and 11 clinical features across 421 patients, 28 significant findings detected with Q value < 0.25.
-
AMP PEAK 11(13Q12.13) MUTATION ANALYSIS cnv correlated to 'HISTOLOGICAL.TYPE'.
-
AMP PEAK 12(13Q22.1) MUTATION ANALYSIS cnv correlated to 'HISTOLOGICAL.TYPE'.
-
AMP PEAK 13(16P11.2) MUTATION ANALYSIS cnv correlated to 'PATHOLOGY.N.STAGE'.
-
AMP PEAK 14(16Q12.1) MUTATION ANALYSIS cnv correlated to 'NEOPLASM.DISEASESTAGE' and 'PATHOLOGY.N.STAGE'.
-
AMP PEAK 20(20Q11.21) MUTATION ANALYSIS cnv correlated to 'HISTOLOGICAL.TYPE'.
-
AMP PEAK 21(20Q12) MUTATION ANALYSIS cnv correlated to 'HISTOLOGICAL.TYPE'.
-
AMP PEAK 22(20Q13.12) MUTATION ANALYSIS cnv correlated to 'HISTOLOGICAL.TYPE'.
-
DEL PEAK 1(1P36.11) MUTATION ANALYSIS cnv correlated to 'PATHOLOGY.M.STAGE'.
-
DEL PEAK 7(4P16.1) MUTATION ANALYSIS cnv correlated to 'PATHOLOGY.N.STAGE'.
-
DEL PEAK 11(5Q21.3) MUTATION ANALYSIS cnv correlated to 'PATHOLOGY.N.STAGE'.
-
DEL PEAK 16(8P23.3) MUTATION ANALYSIS cnv correlated to 'PATHOLOGY.N.STAGE'.
-
DEL PEAK 17(8P22) MUTATION ANALYSIS cnv correlated to 'NEOPLASM.DISEASESTAGE' and 'PATHOLOGY.N.STAGE'.
-
DEL PEAK 19(8P11.21) MUTATION ANALYSIS cnv correlated to 'PATHOLOGY.N.STAGE'.
-
DEL PEAK 25(13Q14.13) MUTATION ANALYSIS cnv correlated to 'PATHOLOGY.M.STAGE'.
-
DEL PEAK 32(17P12) MUTATION ANALYSIS cnv correlated to 'NEOPLASM.DISEASESTAGE', 'PATHOLOGY.N.STAGE', 'HISTOLOGICAL.TYPE', and 'NUMBER.OF.LYMPH.NODES'.
-
DEL PEAK 34(18P11.31) MUTATION ANALYSIS cnv correlated to 'HISTOLOGICAL.TYPE'.
-
DEL PEAK 35(18Q12.2) MUTATION ANALYSIS cnv correlated to 'HISTOLOGICAL.TYPE'.
-
DEL PEAK 36(18Q21.2) MUTATION ANALYSIS cnv correlated to 'NEOPLASM.DISEASESTAGE', 'PATHOLOGY.N.STAGE', and 'HISTOLOGICAL.TYPE'.
-
DEL PEAK 37(18Q22.1) MUTATION ANALYSIS cnv correlated to 'PATHOLOGY.N.STAGE' and 'HISTOLOGICAL.TYPE'.
-
DEL PEAK 38(19P13.3) MUTATION ANALYSIS cnv correlated to 'PATHOLOGY.N.STAGE'.
Table 1. Get Full Table Overview of the association between significant copy number variation of 63 focal events and 11 clinical features. Shown in the table are P values (Q values). Thresholded by Q value < 0.25, 28 significant findings detected.
Clinical Features |
Time to Death |
AGE |
NEOPLASM DISEASESTAGE |
PATHOLOGY T STAGE |
PATHOLOGY N STAGE |
PATHOLOGY M STAGE |
GENDER |
HISTOLOGICAL TYPE |
RADIATIONS RADIATION REGIMENINDICATION |
COMPLETENESS OF RESECTION |
NUMBER OF LYMPH NODES |
||
nCNV (%) | nWild-Type | logrank test | t-test | Chi-square test | Fisher's exact test | Fisher's exact test | Chi-square test | Fisher's exact test | Fisher's exact test | Fisher's exact test | Fisher's exact test | t-test | |
DEL PEAK 32(17P12) MUTATION ANALYSIS | 231 (55%) | 190 |
0.406 (1.00) |
0.0218 (1.00) |
3.71e-05 (0.0253) |
0.887 (1.00) |
2.14e-05 (0.0146) |
0.00853 (1.00) |
0.282 (1.00) |
3.96e-06 (0.00271) |
0.255 (1.00) |
0.17 (1.00) |
0.000117 (0.0787) |
DEL PEAK 36(18Q21 2) MUTATION ANALYSIS | 266 (63%) | 155 |
0.652 (1.00) |
0.148 (1.00) |
0.000236 (0.158) |
0.812 (1.00) |
0.000108 (0.073) |
0.00512 (1.00) |
0.0851 (1.00) |
1.95e-09 (1.34e-06) |
0.3 (1.00) |
0.135 (1.00) |
0.0355 (1.00) |
AMP PEAK 14(16Q12 1) MUTATION ANALYSIS | 103 (24%) | 318 |
0.389 (1.00) |
0.0281 (1.00) |
0.000233 (0.156) |
0.973 (1.00) |
0.000326 (0.217) |
0.28 (1.00) |
0.366 (1.00) |
0.0113 (1.00) |
0.57 (1.00) |
0.737 (1.00) |
0.021 (1.00) |
DEL PEAK 17(8P22) MUTATION ANALYSIS | 189 (45%) | 232 |
0.33 (1.00) |
0.105 (1.00) |
0.000102 (0.0688) |
0.184 (1.00) |
2.16e-06 (0.00148) |
0.000926 (0.605) |
0.141 (1.00) |
0.0132 (1.00) |
0.59 (1.00) |
0.055 (1.00) |
0.00127 (0.824) |
DEL PEAK 37(18Q22 1) MUTATION ANALYSIS | 266 (63%) | 155 |
0.471 (1.00) |
0.247 (1.00) |
0.000657 (0.434) |
0.812 (1.00) |
0.00022 (0.147) |
0.00512 (1.00) |
0.0851 (1.00) |
1.97e-10 (1.36e-07) |
0.3 (1.00) |
0.229 (1.00) |
0.0449 (1.00) |
AMP PEAK 11(13Q12 13) MUTATION ANALYSIS | 256 (61%) | 165 |
0.477 (1.00) |
0.426 (1.00) |
0.0034 (1.00) |
0.972 (1.00) |
0.00246 (1.00) |
0.0044 (1.00) |
0.69 (1.00) |
4.49e-07 (0.000309) |
0.283 (1.00) |
0.0333 (1.00) |
0.0844 (1.00) |
AMP PEAK 12(13Q22 1) MUTATION ANALYSIS | 260 (62%) | 161 |
0.251 (1.00) |
0.461 (1.00) |
0.00382 (1.00) |
0.975 (1.00) |
0.00112 (0.726) |
0.0064 (1.00) |
0.23 (1.00) |
4.48e-06 (0.00306) |
0.29 (1.00) |
0.0689 (1.00) |
0.125 (1.00) |
AMP PEAK 13(16P11 2) MUTATION ANALYSIS | 117 (28%) | 304 |
0.759 (1.00) |
0.107 (1.00) |
0.000767 (0.502) |
0.575 (1.00) |
0.000162 (0.109) |
0.449 (1.00) |
0.448 (1.00) |
0.00898 (1.00) |
1 (1.00) |
0.709 (1.00) |
0.00761 (1.00) |
AMP PEAK 20(20Q11 21) MUTATION ANALYSIS | 302 (72%) | 119 |
0.632 (1.00) |
0.631 (1.00) |
0.00327 (1.00) |
0.28 (1.00) |
0.0237 (1.00) |
0.00954 (1.00) |
0.234 (1.00) |
3.43e-06 (0.00235) |
0.562 (1.00) |
0.129 (1.00) |
0.134 (1.00) |
AMP PEAK 21(20Q12) MUTATION ANALYSIS | 303 (72%) | 118 |
0.581 (1.00) |
0.671 (1.00) |
0.00131 (0.846) |
0.396 (1.00) |
0.0298 (1.00) |
0.00442 (1.00) |
0.194 (1.00) |
5.53e-07 (0.00038) |
0.563 (1.00) |
0.13 (1.00) |
0.172 (1.00) |
AMP PEAK 22(20Q13 12) MUTATION ANALYSIS | 306 (73%) | 115 |
0.425 (1.00) |
0.672 (1.00) |
0.000673 (0.444) |
0.51 (1.00) |
0.0194 (1.00) |
0.00236 (1.00) |
0.273 (1.00) |
1.18e-06 (0.000811) |
0.565 (1.00) |
0.126 (1.00) |
0.0586 (1.00) |
DEL PEAK 1(1P36 11) MUTATION ANALYSIS | 151 (36%) | 270 |
0.0307 (1.00) |
0.238 (1.00) |
0.00743 (1.00) |
0.659 (1.00) |
0.0107 (1.00) |
0.000156 (0.105) |
0.542 (1.00) |
0.00381 (1.00) |
1 (1.00) |
0.107 (1.00) |
0.00756 (1.00) |
DEL PEAK 7(4P16 1) MUTATION ANALYSIS | 124 (29%) | 297 |
0.0207 (1.00) |
0.629 (1.00) |
0.00109 (0.711) |
0.842 (1.00) |
0.000347 (0.231) |
0.000496 (0.329) |
0.454 (1.00) |
0.0256 (1.00) |
0.0251 (1.00) |
0.0331 (1.00) |
0.0104 (1.00) |
DEL PEAK 11(5Q21 3) MUTATION ANALYSIS | 118 (28%) | 303 |
0.249 (1.00) |
0.121 (1.00) |
0.00163 (1.00) |
0.968 (1.00) |
6.03e-05 (0.0409) |
0.0197 (1.00) |
0.744 (1.00) |
0.198 (1.00) |
0.0216 (1.00) |
0.249 (1.00) |
0.00699 (1.00) |
DEL PEAK 16(8P23 3) MUTATION ANALYSIS | 175 (42%) | 246 |
0.845 (1.00) |
0.246 (1.00) |
0.00622 (1.00) |
0.135 (1.00) |
0.000164 (0.11) |
0.0169 (1.00) |
0.0742 (1.00) |
0.0558 (1.00) |
0.573 (1.00) |
0.108 (1.00) |
0.00599 (1.00) |
DEL PEAK 19(8P11 21) MUTATION ANALYSIS | 44 (10%) | 377 |
0.731 (1.00) |
0.433 (1.00) |
0.00224 (1.00) |
0.132 (1.00) |
0.00022 (0.148) |
0.00992 (1.00) |
1 (1.00) |
0.488 (1.00) |
0.283 (1.00) |
0.111 (1.00) |
0.0172 (1.00) |
DEL PEAK 25(13Q14 13) MUTATION ANALYSIS | 18 (4%) | 403 |
0.228 (1.00) |
0.296 (1.00) |
0.000699 (0.46) |
0.67 (1.00) |
0.0647 (1.00) |
3.48e-05 (0.0237) |
1 (1.00) |
1 (1.00) |
1 (1.00) |
0.868 (1.00) |
0.229 (1.00) |
DEL PEAK 34(18P11 31) MUTATION ANALYSIS | 226 (54%) | 195 |
0.983 (1.00) |
0.0302 (1.00) |
0.0117 (1.00) |
0.94 (1.00) |
0.0602 (1.00) |
0.00309 (1.00) |
0.845 (1.00) |
4.02e-11 (2.79e-08) |
0.252 (1.00) |
0.0286 (1.00) |
0.462 (1.00) |
DEL PEAK 35(18Q12 2) MUTATION ANALYSIS | 253 (60%) | 168 |
0.92 (1.00) |
0.0826 (1.00) |
0.00211 (1.00) |
0.71 (1.00) |
0.00162 (1.00) |
0.0109 (1.00) |
0.273 (1.00) |
1.41e-10 (9.74e-08) |
0.279 (1.00) |
0.144 (1.00) |
0.128 (1.00) |
DEL PEAK 38(19P13 3) MUTATION ANALYSIS | 58 (14%) | 363 |
0.66 (1.00) |
0.141 (1.00) |
0.000392 (0.261) |
0.965 (1.00) |
5.88e-05 (0.0399) |
0.02 (1.00) |
0.671 (1.00) |
0.203 (1.00) |
0.36 (1.00) |
0.0791 (1.00) |
0.00175 (1.00) |
AMP PEAK 1(2Q33 1) MUTATION ANALYSIS | 81 (19%) | 340 |
0.0213 (1.00) |
0.329 (1.00) |
0.208 (1.00) |
0.97 (1.00) |
0.0404 (1.00) |
0.364 (1.00) |
0.387 (1.00) |
0.463 (1.00) |
0.474 (1.00) |
0.101 (1.00) |
0.0969 (1.00) |
AMP PEAK 2(5P13 2) MUTATION ANALYSIS | 82 (19%) | 339 |
0.959 (1.00) |
0.221 (1.00) |
0.146 (1.00) |
0.448 (1.00) |
0.0591 (1.00) |
0.691 (1.00) |
0.388 (1.00) |
1 (1.00) |
1 (1.00) |
0.175 (1.00) |
0.0594 (1.00) |
AMP PEAK 3(5Q22 3) MUTATION ANALYSIS | 41 (10%) | 380 |
0.513 (1.00) |
0.668 (1.00) |
0.465 (1.00) |
0.839 (1.00) |
0.309 (1.00) |
0.0122 (1.00) |
0.869 (1.00) |
0.333 (1.00) |
0.265 (1.00) |
0.0962 (1.00) |
0.319 (1.00) |
AMP PEAK 4(6P21 1) MUTATION ANALYSIS | 91 (22%) | 330 |
0.493 (1.00) |
0.761 (1.00) |
0.0548 (1.00) |
0.472 (1.00) |
0.00347 (1.00) |
0.603 (1.00) |
0.343 (1.00) |
0.0512 (1.00) |
0.00984 (1.00) |
0.573 (1.00) |
0.016 (1.00) |
AMP PEAK 5(8P11 23) MUTATION ANALYSIS | 147 (35%) | 274 |
0.877 (1.00) |
0.4 (1.00) |
0.365 (1.00) |
0.659 (1.00) |
0.776 (1.00) |
0.472 (1.00) |
0.759 (1.00) |
0.13 (1.00) |
0.28 (1.00) |
0.813 (1.00) |
0.693 (1.00) |
AMP PEAK 6(8P11 21) MUTATION ANALYSIS | 176 (42%) | 245 |
0.498 (1.00) |
0.604 (1.00) |
0.647 (1.00) |
0.68 (1.00) |
0.569 (1.00) |
0.451 (1.00) |
0.276 (1.00) |
0.145 (1.00) |
0.574 (1.00) |
0.312 (1.00) |
0.963 (1.00) |
AMP PEAK 7(8Q12 1) MUTATION ANALYSIS | 218 (52%) | 203 |
0.798 (1.00) |
0.196 (1.00) |
0.791 (1.00) |
0.418 (1.00) |
0.577 (1.00) |
0.168 (1.00) |
0.845 (1.00) |
0.0139 (1.00) |
0.249 (1.00) |
0.461 (1.00) |
0.103 (1.00) |
AMP PEAK 8(8Q24 21) MUTATION ANALYSIS | 243 (58%) | 178 |
0.743 (1.00) |
0.124 (1.00) |
0.347 (1.00) |
0.175 (1.00) |
0.392 (1.00) |
0.11 (1.00) |
0.43 (1.00) |
0.0568 (1.00) |
0.266 (1.00) |
0.401 (1.00) |
0.0881 (1.00) |
AMP PEAK 9(11P15 5) MUTATION ANALYSIS | 87 (21%) | 334 |
0.723 (1.00) |
0.0455 (1.00) |
0.809 (1.00) |
0.135 (1.00) |
0.18 (1.00) |
0.23 (1.00) |
0.549 (1.00) |
0.00196 (1.00) |
0.11 (1.00) |
0.46 (1.00) |
0.295 (1.00) |
AMP PEAK 10(12P13 33) MUTATION ANALYSIS | 104 (25%) | 317 |
0.127 (1.00) |
0.0865 (1.00) |
0.214 (1.00) |
0.124 (1.00) |
0.282 (1.00) |
0.227 (1.00) |
1 (1.00) |
0.738 (1.00) |
1 (1.00) |
0.462 (1.00) |
0.836 (1.00) |
AMP PEAK 15(17Q12) MUTATION ANALYSIS | 102 (24%) | 319 |
0.492 (1.00) |
0.445 (1.00) |
0.151 (1.00) |
0.334 (1.00) |
0.151 (1.00) |
0.0109 (1.00) |
0.254 (1.00) |
0.313 (1.00) |
0.566 (1.00) |
0.277 (1.00) |
0.172 (1.00) |
AMP PEAK 16(17Q24 1) MUTATION ANALYSIS | 93 (22%) | 328 |
0.0947 (1.00) |
0.403 (1.00) |
0.416 (1.00) |
0.421 (1.00) |
0.306 (1.00) |
0.0284 (1.00) |
0.725 (1.00) |
0.0821 (1.00) |
0.528 (1.00) |
0.427 (1.00) |
0.964 (1.00) |
AMP PEAK 17(19P13 2) MUTATION ANALYSIS | 67 (16%) | 354 |
0.932 (1.00) |
0.754 (1.00) |
0.539 (1.00) |
0.774 (1.00) |
0.0197 (1.00) |
0.0051 (1.00) |
0.0326 (1.00) |
0.168 (1.00) |
0.406 (1.00) |
0.104 (1.00) |
0.305 (1.00) |
AMP PEAK 18(19Q13 11) MUTATION ANALYSIS | 84 (20%) | 337 |
0.239 (1.00) |
0.625 (1.00) |
0.635 (1.00) |
0.966 (1.00) |
0.122 (1.00) |
0.0166 (1.00) |
0.0511 (1.00) |
0.366 (1.00) |
0.488 (1.00) |
0.598 (1.00) |
0.988 (1.00) |
AMP PEAK 19(20P11 23) MUTATION ANALYSIS | 205 (49%) | 216 |
0.684 (1.00) |
0.764 (1.00) |
0.000725 (0.476) |
0.966 (1.00) |
0.102 (1.00) |
0.000689 (0.454) |
0.328 (1.00) |
0.0135 (1.00) |
0.115 (1.00) |
0.0305 (1.00) |
0.263 (1.00) |
DEL PEAK 2(1P33) MUTATION ANALYSIS | 107 (25%) | 314 |
0.00574 (1.00) |
0.631 (1.00) |
0.0294 (1.00) |
0.509 (1.00) |
0.0101 (1.00) |
0.00683 (1.00) |
1 (1.00) |
0.0999 (1.00) |
0.574 (1.00) |
0.263 (1.00) |
0.0171 (1.00) |
DEL PEAK 3(2Q37 2) MUTATION ANALYSIS | 21 (5%) | 400 |
0.304 (1.00) |
0.417 (1.00) |
0.814 (1.00) |
0.445 (1.00) |
0.82 (1.00) |
0.343 (1.00) |
0.373 (1.00) |
0.747 (1.00) |
1 (1.00) |
0.216 (1.00) |
0.155 (1.00) |
DEL PEAK 4(3P26 1) MUTATION ANALYSIS | 61 (14%) | 360 |
0.00569 (1.00) |
0.351 (1.00) |
0.00867 (1.00) |
0.0491 (1.00) |
0.0211 (1.00) |
0.000577 (0.382) |
1 (1.00) |
0.148 (1.00) |
1 (1.00) |
0.0735 (1.00) |
0.203 (1.00) |
DEL PEAK 5(3P14 2) MUTATION ANALYSIS | 77 (18%) | 344 |
0.849 (1.00) |
0.56 (1.00) |
0.159 (1.00) |
0.172 (1.00) |
0.0495 (1.00) |
0.0633 (1.00) |
0.45 (1.00) |
0.139 (1.00) |
1 (1.00) |
0.5 (1.00) |
0.0357 (1.00) |
DEL PEAK 6(3Q26 31) MUTATION ANALYSIS | 41 (10%) | 380 |
0.162 (1.00) |
0.813 (1.00) |
0.0786 (1.00) |
0.0743 (1.00) |
0.742 (1.00) |
0.824 (1.00) |
1 (1.00) |
0.141 (1.00) |
1 (1.00) |
0.851 (1.00) |
0.315 (1.00) |
DEL PEAK 8(4Q22 1) MUTATION ANALYSIS | 130 (31%) | 291 |
0.128 (1.00) |
0.895 (1.00) |
0.00692 (1.00) |
0.256 (1.00) |
0.00117 (0.759) |
0.0975 (1.00) |
0.462 (1.00) |
0.0122 (1.00) |
0.029 (1.00) |
0.897 (1.00) |
0.0206 (1.00) |
DEL PEAK 9(4Q35 1) MUTATION ANALYSIS | 140 (33%) | 281 |
0.182 (1.00) |
0.305 (1.00) |
0.148 (1.00) |
0.639 (1.00) |
0.0065 (1.00) |
0.165 (1.00) |
0.254 (1.00) |
0.065 (1.00) |
0.0362 (1.00) |
0.324 (1.00) |
0.0737 (1.00) |
DEL PEAK 10(5Q11 2) MUTATION ANALYSIS | 92 (22%) | 329 |
0.127 (1.00) |
0.0795 (1.00) |
0.0176 (1.00) |
0.933 (1.00) |
0.00278 (1.00) |
0.0504 (1.00) |
0.408 (1.00) |
0.0357 (1.00) |
0.122 (1.00) |
0.719 (1.00) |
0.0186 (1.00) |
DEL PEAK 12(5Q23 1) MUTATION ANALYSIS | 108 (26%) | 313 |
0.491 (1.00) |
0.424 (1.00) |
0.0749 (1.00) |
0.943 (1.00) |
0.00537 (1.00) |
0.01 (1.00) |
0.264 (1.00) |
0.0989 (1.00) |
0.0165 (1.00) |
0.267 (1.00) |
0.036 (1.00) |
DEL PEAK 13(6P25 3) MUTATION ANALYSIS | 54 (13%) | 367 |
0.581 (1.00) |
0.0791 (1.00) |
0.649 (1.00) |
0.118 (1.00) |
0.844 (1.00) |
0.18 (1.00) |
0.0805 (1.00) |
0.517 (1.00) |
1 (1.00) |
0.376 (1.00) |
0.765 (1.00) |
DEL PEAK 14(6Q26) MUTATION ANALYSIS | 60 (14%) | 361 |
0.0973 (1.00) |
0.857 (1.00) |
0.0531 (1.00) |
0.188 (1.00) |
0.0192 (1.00) |
0.0223 (1.00) |
0.889 (1.00) |
1 (1.00) |
1 (1.00) |
0.078 (1.00) |
0.0163 (1.00) |
DEL PEAK 15(7Q31 1) MUTATION ANALYSIS | 11 (3%) | 410 |
0.725 (1.00) |
0.612 (1.00) |
0.935 (1.00) |
0.614 (1.00) |
1 (1.00) |
0.484 (1.00) |
0.36 (1.00) |
1 (1.00) |
1 (1.00) |
1 (1.00) |
0.647 (1.00) |
DEL PEAK 18(8P11 22) MUTATION ANALYSIS | 83 (20%) | 338 |
0.644 (1.00) |
0.21 (1.00) |
0.0131 (1.00) |
0.271 (1.00) |
0.000496 (0.329) |
0.0684 (1.00) |
0.541 (1.00) |
0.365 (1.00) |
0.101 (1.00) |
0.193 (1.00) |
0.03 (1.00) |
DEL PEAK 20(9P21 3) MUTATION ANALYSIS | 57 (14%) | 364 |
0.0972 (1.00) |
0.0569 (1.00) |
0.469 (1.00) |
0.339 (1.00) |
0.174 (1.00) |
0.0923 (1.00) |
0.203 (1.00) |
0.203 (1.00) |
1 (1.00) |
0.64 (1.00) |
0.315 (1.00) |
DEL PEAK 21(10P15 3) MUTATION ANALYSIS | 69 (16%) | 352 |
0.999 (1.00) |
0.445 (1.00) |
0.00148 (0.953) |
0.865 (1.00) |
0.00238 (1.00) |
0.00296 (1.00) |
0.895 (1.00) |
0.559 (1.00) |
0.0711 (1.00) |
0.525 (1.00) |
0.0808 (1.00) |
DEL PEAK 22(10Q21 1) MUTATION ANALYSIS | 84 (20%) | 337 |
0.866 (1.00) |
0.0569 (1.00) |
0.000738 (0.484) |
0.946 (1.00) |
0.0038 (1.00) |
0.0504 (1.00) |
0.541 (1.00) |
0.0727 (1.00) |
0.103 (1.00) |
0.0356 (1.00) |
0.0765 (1.00) |
DEL PEAK 23(10Q23 31) MUTATION ANALYSIS | 96 (23%) | 325 |
0.83 (1.00) |
0.0215 (1.00) |
0.00111 (0.72) |
0.587 (1.00) |
0.0037 (1.00) |
0.00354 (1.00) |
0.485 (1.00) |
0.166 (1.00) |
0.132 (1.00) |
0.13 (1.00) |
0.106 (1.00) |
DEL PEAK 24(10Q25 2) MUTATION ANALYSIS | 95 (23%) | 326 |
0.397 (1.00) |
0.18 (1.00) |
0.0135 (1.00) |
0.186 (1.00) |
0.00141 (0.914) |
0.0328 (1.00) |
1 (1.00) |
0.166 (1.00) |
0.129 (1.00) |
0.0413 (1.00) |
0.0754 (1.00) |
DEL PEAK 26(14Q32 11) MUTATION ANALYSIS | 135 (32%) | 286 |
0.281 (1.00) |
0.695 (1.00) |
0.101 (1.00) |
0.562 (1.00) |
0.0611 (1.00) |
0.022 (1.00) |
0.754 (1.00) |
0.000941 (0.614) |
0.554 (1.00) |
0.276 (1.00) |
0.139 (1.00) |
DEL PEAK 27(15Q11 2) MUTATION ANALYSIS | 162 (38%) | 259 |
0.822 (1.00) |
0.985 (1.00) |
0.0346 (1.00) |
0.969 (1.00) |
0.00536 (1.00) |
0.0428 (1.00) |
1 (1.00) |
0.0174 (1.00) |
0.0563 (1.00) |
0.475 (1.00) |
0.234 (1.00) |
DEL PEAK 28(15Q21 1) MUTATION ANALYSIS | 152 (36%) | 269 |
0.198 (1.00) |
0.873 (1.00) |
0.235 (1.00) |
0.977 (1.00) |
0.0433 (1.00) |
0.0638 (1.00) |
0.919 (1.00) |
0.0231 (1.00) |
0.0465 (1.00) |
0.316 (1.00) |
0.448 (1.00) |
DEL PEAK 29(15Q22 33) MUTATION ANALYSIS | 146 (35%) | 275 |
0.432 (1.00) |
0.604 (1.00) |
0.0497 (1.00) |
0.547 (1.00) |
0.0173 (1.00) |
0.0295 (1.00) |
0.918 (1.00) |
0.00607 (1.00) |
0.0411 (1.00) |
0.87 (1.00) |
0.313 (1.00) |
DEL PEAK 30(16P13 3) MUTATION ANALYSIS | 46 (11%) | 375 |
0.00145 (0.935) |
0.371 (1.00) |
0.101 (1.00) |
0.028 (1.00) |
0.117 (1.00) |
0.443 (1.00) |
1 (1.00) |
1 (1.00) |
1 (1.00) |
0.76 (1.00) |
0.129 (1.00) |
DEL PEAK 31(16Q23 1) MUTATION ANALYSIS | 50 (12%) | 371 |
0.0237 (1.00) |
0.248 (1.00) |
0.901 (1.00) |
0.5 (1.00) |
0.579 (1.00) |
0.981 (1.00) |
0.0971 (1.00) |
0.506 (1.00) |
1 (1.00) |
0.95 (1.00) |
0.201 (1.00) |
DEL PEAK 33(17Q24 3) MUTATION ANALYSIS | 60 (14%) | 361 |
0.849 (1.00) |
0.596 (1.00) |
0.0533 (1.00) |
0.712 (1.00) |
0.00528 (1.00) |
0.301 (1.00) |
0.328 (1.00) |
1 (1.00) |
1 (1.00) |
0.25 (1.00) |
0.0364 (1.00) |
DEL PEAK 39(20P12 1) MUTATION ANALYSIS | 79 (19%) | 342 |
0.942 (1.00) |
0.66 (1.00) |
0.469 (1.00) |
0.665 (1.00) |
0.389 (1.00) |
0.982 (1.00) |
0.618 (1.00) |
0.138 (1.00) |
1 (1.00) |
0.73 (1.00) |
0.586 (1.00) |
DEL PEAK 40(21Q11 2) MUTATION ANALYSIS | 128 (30%) | 293 |
0.922 (1.00) |
0.727 (1.00) |
0.353 (1.00) |
0.352 (1.00) |
0.0479 (1.00) |
0.278 (1.00) |
0.751 (1.00) |
0.00693 (1.00) |
0.221 (1.00) |
0.831 (1.00) |
0.0142 (1.00) |
DEL PEAK 41(22Q13 32) MUTATION ANALYSIS | 143 (34%) | 278 |
0.326 (1.00) |
0.661 (1.00) |
0.0133 (1.00) |
0.721 (1.00) |
0.00148 (0.954) |
0.0268 (1.00) |
1 (1.00) |
0.00225 (1.00) |
1 (1.00) |
0.503 (1.00) |
0.0116 (1.00) |
P value = 4.49e-07 (Fisher's exact test), Q value = 0.00031
Table S1. Gene #11: 'AMP PEAK 11(13Q12.13) MUTATION STATUS' versus Clinical Feature #8: 'HISTOLOGICAL.TYPE'
nPatients | COLON ADENOCARCINOMA | COLON MUCINOUS ADENOCARCINOMA |
---|---|---|
ALL | 364 | 55 |
AMP PEAK 11(13Q12.13) MUTATED | 239 | 16 |
AMP PEAK 11(13Q12.13) WILD-TYPE | 125 | 39 |
Figure S1. Get High-res Image Gene #11: 'AMP PEAK 11(13Q12.13) MUTATION STATUS' versus Clinical Feature #8: 'HISTOLOGICAL.TYPE'
![](D11V8.png)
P value = 4.48e-06 (Fisher's exact test), Q value = 0.0031
Table S2. Gene #12: 'AMP PEAK 12(13Q22.1) MUTATION STATUS' versus Clinical Feature #8: 'HISTOLOGICAL.TYPE'
nPatients | COLON ADENOCARCINOMA | COLON MUCINOUS ADENOCARCINOMA |
---|---|---|
ALL | 364 | 55 |
AMP PEAK 12(13Q22.1) MUTATED | 241 | 18 |
AMP PEAK 12(13Q22.1) WILD-TYPE | 123 | 37 |
Figure S2. Get High-res Image Gene #12: 'AMP PEAK 12(13Q22.1) MUTATION STATUS' versus Clinical Feature #8: 'HISTOLOGICAL.TYPE'
![](D12V8.png)
P value = 0.000162 (Fisher's exact test), Q value = 0.11
Table S3. Gene #13: 'AMP PEAK 13(16P11.2) MUTATION STATUS' versus Clinical Feature #5: 'PATHOLOGY.N.STAGE'
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 246 | 100 | 74 |
AMP PEAK 13(16P11.2) MUTATED | 50 | 36 | 31 |
AMP PEAK 13(16P11.2) WILD-TYPE | 196 | 64 | 43 |
Figure S3. Get High-res Image Gene #13: 'AMP PEAK 13(16P11.2) MUTATION STATUS' versus Clinical Feature #5: 'PATHOLOGY.N.STAGE'
![](D13V5.png)
P value = 0.000233 (Chi-square test), Q value = 0.16
Table S4. Gene #14: 'AMP PEAK 14(16Q12.1) MUTATION STATUS' versus Clinical Feature #3: 'NEOPLASM.DISEASESTAGE'
nPatients | STAGE I | STAGE IA | STAGE II | STAGE IIA | STAGE IIB | STAGE IIC | STAGE III | STAGE IIIA | STAGE IIIB | STAGE IIIC | STAGE IV | STAGE IVA | STAGE IVB |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ALL | 70 | 1 | 33 | 118 | 8 | 1 | 22 | 13 | 52 | 35 | 42 | 16 | 1 |
AMP PEAK 14(16Q12.1) MUTATED | 12 | 1 | 3 | 21 | 1 | 0 | 5 | 9 | 20 | 13 | 11 | 3 | 0 |
AMP PEAK 14(16Q12.1) WILD-TYPE | 58 | 0 | 30 | 97 | 7 | 1 | 17 | 4 | 32 | 22 | 31 | 13 | 1 |
Figure S4. Get High-res Image Gene #14: 'AMP PEAK 14(16Q12.1) MUTATION STATUS' versus Clinical Feature #3: 'NEOPLASM.DISEASESTAGE'
![](D14V3.png)
P value = 0.000326 (Fisher's exact test), Q value = 0.22
Table S5. Gene #14: 'AMP PEAK 14(16Q12.1) MUTATION STATUS' versus Clinical Feature #5: 'PATHOLOGY.N.STAGE'
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 246 | 100 | 74 |
AMP PEAK 14(16Q12.1) MUTATED | 43 | 34 | 26 |
AMP PEAK 14(16Q12.1) WILD-TYPE | 203 | 66 | 48 |
Figure S5. Get High-res Image Gene #14: 'AMP PEAK 14(16Q12.1) MUTATION STATUS' versus Clinical Feature #5: 'PATHOLOGY.N.STAGE'
![](D14V5.png)
P value = 3.43e-06 (Fisher's exact test), Q value = 0.0023
Table S6. Gene #20: 'AMP PEAK 20(20Q11.21) MUTATION STATUS' versus Clinical Feature #8: 'HISTOLOGICAL.TYPE'
nPatients | COLON ADENOCARCINOMA | COLON MUCINOUS ADENOCARCINOMA |
---|---|---|
ALL | 364 | 55 |
AMP PEAK 20(20Q11.21) MUTATED | 276 | 24 |
AMP PEAK 20(20Q11.21) WILD-TYPE | 88 | 31 |
Figure S6. Get High-res Image Gene #20: 'AMP PEAK 20(20Q11.21) MUTATION STATUS' versus Clinical Feature #8: 'HISTOLOGICAL.TYPE'
![](D20V8.png)
P value = 5.53e-07 (Fisher's exact test), Q value = 0.00038
Table S7. Gene #21: 'AMP PEAK 21(20Q12) MUTATION STATUS' versus Clinical Feature #8: 'HISTOLOGICAL.TYPE'
nPatients | COLON ADENOCARCINOMA | COLON MUCINOUS ADENOCARCINOMA |
---|---|---|
ALL | 364 | 55 |
AMP PEAK 21(20Q12) MUTATED | 278 | 23 |
AMP PEAK 21(20Q12) WILD-TYPE | 86 | 32 |
Figure S7. Get High-res Image Gene #21: 'AMP PEAK 21(20Q12) MUTATION STATUS' versus Clinical Feature #8: 'HISTOLOGICAL.TYPE'
![](D21V8.png)
P value = 1.18e-06 (Fisher's exact test), Q value = 0.00081
Table S8. Gene #22: 'AMP PEAK 22(20Q13.12) MUTATION STATUS' versus Clinical Feature #8: 'HISTOLOGICAL.TYPE'
nPatients | COLON ADENOCARCINOMA | COLON MUCINOUS ADENOCARCINOMA |
---|---|---|
ALL | 364 | 55 |
AMP PEAK 22(20Q13.12) MUTATED | 280 | 24 |
AMP PEAK 22(20Q13.12) WILD-TYPE | 84 | 31 |
Figure S8. Get High-res Image Gene #22: 'AMP PEAK 22(20Q13.12) MUTATION STATUS' versus Clinical Feature #8: 'HISTOLOGICAL.TYPE'
![](D22V8.png)
P value = 0.000156 (Chi-square test), Q value = 0.11
Table S9. Gene #23: 'DEL PEAK 1(1P36.11) MUTATION STATUS' versus Clinical Feature #6: 'PATHOLOGY.M.STAGE'
nPatients | M0 | M1 | M1A | M1B | MX |
---|---|---|---|---|---|
ALL | 317 | 50 | 7 | 1 | 39 |
DEL PEAK 1(1P36.11) MUTATED | 101 | 33 | 2 | 0 | 14 |
DEL PEAK 1(1P36.11) WILD-TYPE | 216 | 17 | 5 | 1 | 25 |
Figure S9. Get High-res Image Gene #23: 'DEL PEAK 1(1P36.11) MUTATION STATUS' versus Clinical Feature #6: 'PATHOLOGY.M.STAGE'
![](D23V6.png)
P value = 0.000347 (Fisher's exact test), Q value = 0.23
Table S10. Gene #29: 'DEL PEAK 7(4P16.1) MUTATION STATUS' versus Clinical Feature #5: 'PATHOLOGY.N.STAGE'
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 246 | 100 | 74 |
DEL PEAK 7(4P16.1) MUTATED | 55 | 36 | 33 |
DEL PEAK 7(4P16.1) WILD-TYPE | 191 | 64 | 41 |
Figure S10. Get High-res Image Gene #29: 'DEL PEAK 7(4P16.1) MUTATION STATUS' versus Clinical Feature #5: 'PATHOLOGY.N.STAGE'
![](D29V5.png)
P value = 6.03e-05 (Fisher's exact test), Q value = 0.041
Table S11. Gene #33: 'DEL PEAK 11(5Q21.3) MUTATION STATUS' versus Clinical Feature #5: 'PATHOLOGY.N.STAGE'
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 246 | 100 | 74 |
DEL PEAK 11(5Q21.3) MUTATED | 50 | 35 | 33 |
DEL PEAK 11(5Q21.3) WILD-TYPE | 196 | 65 | 41 |
Figure S11. Get High-res Image Gene #33: 'DEL PEAK 11(5Q21.3) MUTATION STATUS' versus Clinical Feature #5: 'PATHOLOGY.N.STAGE'
![](D33V5.png)
P value = 0.000164 (Fisher's exact test), Q value = 0.11
Table S12. Gene #38: 'DEL PEAK 16(8P23.3) MUTATION STATUS' versus Clinical Feature #5: 'PATHOLOGY.N.STAGE'
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 246 | 100 | 74 |
DEL PEAK 16(8P23.3) MUTATED | 82 | 49 | 43 |
DEL PEAK 16(8P23.3) WILD-TYPE | 164 | 51 | 31 |
Figure S12. Get High-res Image Gene #38: 'DEL PEAK 16(8P23.3) MUTATION STATUS' versus Clinical Feature #5: 'PATHOLOGY.N.STAGE'
![](D38V5.png)
P value = 0.000102 (Chi-square test), Q value = 0.069
Table S13. Gene #39: 'DEL PEAK 17(8P22) MUTATION STATUS' versus Clinical Feature #3: 'NEOPLASM.DISEASESTAGE'
nPatients | STAGE I | STAGE IA | STAGE II | STAGE IIA | STAGE IIB | STAGE IIC | STAGE III | STAGE IIIA | STAGE IIIB | STAGE IIIC | STAGE IV | STAGE IVA | STAGE IVB |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ALL | 70 | 1 | 33 | 118 | 8 | 1 | 22 | 13 | 52 | 35 | 42 | 16 | 1 |
DEL PEAK 17(8P22) MUTATED | 24 | 0 | 9 | 41 | 2 | 0 | 11 | 8 | 27 | 23 | 28 | 12 | 1 |
DEL PEAK 17(8P22) WILD-TYPE | 46 | 1 | 24 | 77 | 6 | 1 | 11 | 5 | 25 | 12 | 14 | 4 | 0 |
Figure S13. Get High-res Image Gene #39: 'DEL PEAK 17(8P22) MUTATION STATUS' versus Clinical Feature #3: 'NEOPLASM.DISEASESTAGE'
![](D39V3.png)
P value = 2.16e-06 (Fisher's exact test), Q value = 0.0015
Table S14. Gene #39: 'DEL PEAK 17(8P22) MUTATION STATUS' versus Clinical Feature #5: 'PATHOLOGY.N.STAGE'
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 246 | 100 | 74 |
DEL PEAK 17(8P22) MUTATED | 86 | 53 | 49 |
DEL PEAK 17(8P22) WILD-TYPE | 160 | 47 | 25 |
Figure S14. Get High-res Image Gene #39: 'DEL PEAK 17(8P22) MUTATION STATUS' versus Clinical Feature #5: 'PATHOLOGY.N.STAGE'
![](D39V5.png)
P value = 0.00022 (Fisher's exact test), Q value = 0.15
Table S15. Gene #41: 'DEL PEAK 19(8P11.21) MUTATION STATUS' versus Clinical Feature #5: 'PATHOLOGY.N.STAGE'
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 246 | 100 | 74 |
DEL PEAK 19(8P11.21) MUTATED | 14 | 14 | 16 |
DEL PEAK 19(8P11.21) WILD-TYPE | 232 | 86 | 58 |
Figure S15. Get High-res Image Gene #41: 'DEL PEAK 19(8P11.21) MUTATION STATUS' versus Clinical Feature #5: 'PATHOLOGY.N.STAGE'
![](D41V5.png)
P value = 3.48e-05 (Chi-square test), Q value = 0.024
Table S16. Gene #47: 'DEL PEAK 25(13Q14.13) MUTATION STATUS' versus Clinical Feature #6: 'PATHOLOGY.M.STAGE'
nPatients | M0 | M1 | M1A | M1B | MX |
---|---|---|---|---|---|
ALL | 317 | 50 | 7 | 1 | 39 |
DEL PEAK 25(13Q14.13) MUTATED | 12 | 1 | 0 | 1 | 2 |
DEL PEAK 25(13Q14.13) WILD-TYPE | 305 | 49 | 7 | 0 | 37 |
Figure S16. Get High-res Image Gene #47: 'DEL PEAK 25(13Q14.13) MUTATION STATUS' versus Clinical Feature #6: 'PATHOLOGY.M.STAGE'
![](D47V6.png)
P value = 3.71e-05 (Chi-square test), Q value = 0.025
Table S17. Gene #54: 'DEL PEAK 32(17P12) MUTATION STATUS' versus Clinical Feature #3: 'NEOPLASM.DISEASESTAGE'
nPatients | STAGE I | STAGE IA | STAGE II | STAGE IIA | STAGE IIB | STAGE IIC | STAGE III | STAGE IIIA | STAGE IIIB | STAGE IIIC | STAGE IV | STAGE IVA | STAGE IVB |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ALL | 70 | 1 | 33 | 118 | 8 | 1 | 22 | 13 | 52 | 35 | 42 | 16 | 1 |
DEL PEAK 32(17P12) MUTATED | 34 | 0 | 15 | 49 | 1 | 1 | 13 | 12 | 31 | 26 | 32 | 11 | 1 |
DEL PEAK 32(17P12) WILD-TYPE | 36 | 1 | 18 | 69 | 7 | 0 | 9 | 1 | 21 | 9 | 10 | 5 | 0 |
Figure S17. Get High-res Image Gene #54: 'DEL PEAK 32(17P12) MUTATION STATUS' versus Clinical Feature #3: 'NEOPLASM.DISEASESTAGE'
![](D54V3.png)
P value = 2.14e-05 (Fisher's exact test), Q value = 0.015
Table S18. Gene #54: 'DEL PEAK 32(17P12) MUTATION STATUS' versus Clinical Feature #5: 'PATHOLOGY.N.STAGE'
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 246 | 100 | 74 |
DEL PEAK 32(17P12) MUTATED | 112 | 65 | 53 |
DEL PEAK 32(17P12) WILD-TYPE | 134 | 35 | 21 |
Figure S18. Get High-res Image Gene #54: 'DEL PEAK 32(17P12) MUTATION STATUS' versus Clinical Feature #5: 'PATHOLOGY.N.STAGE'
![](D54V5.png)
P value = 3.96e-06 (Fisher's exact test), Q value = 0.0027
Table S19. Gene #54: 'DEL PEAK 32(17P12) MUTATION STATUS' versus Clinical Feature #8: 'HISTOLOGICAL.TYPE'
nPatients | COLON ADENOCARCINOMA | COLON MUCINOUS ADENOCARCINOMA |
---|---|---|
ALL | 364 | 55 |
DEL PEAK 32(17P12) MUTATED | 215 | 14 |
DEL PEAK 32(17P12) WILD-TYPE | 149 | 41 |
Figure S19. Get High-res Image Gene #54: 'DEL PEAK 32(17P12) MUTATION STATUS' versus Clinical Feature #8: 'HISTOLOGICAL.TYPE'
![](D54V8.png)
P value = 0.000117 (t-test), Q value = 0.079
Table S20. Gene #54: 'DEL PEAK 32(17P12) MUTATION STATUS' versus Clinical Feature #11: 'NUMBER.OF.LYMPH.NODES'
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 397 | 2.1 (4.5) |
DEL PEAK 32(17P12) MUTATED | 218 | 2.8 (5.5) |
DEL PEAK 32(17P12) WILD-TYPE | 179 | 1.2 (2.6) |
Figure S20. Get High-res Image Gene #54: 'DEL PEAK 32(17P12) MUTATION STATUS' versus Clinical Feature #11: 'NUMBER.OF.LYMPH.NODES'
![](D54V11.png)
P value = 4.02e-11 (Fisher's exact test), Q value = 2.8e-08
Table S21. Gene #56: 'DEL PEAK 34(18P11.31) MUTATION STATUS' versus Clinical Feature #8: 'HISTOLOGICAL.TYPE'
nPatients | COLON ADENOCARCINOMA | COLON MUCINOUS ADENOCARCINOMA |
---|---|---|
ALL | 364 | 55 |
DEL PEAK 34(18P11.31) MUTATED | 217 | 7 |
DEL PEAK 34(18P11.31) WILD-TYPE | 147 | 48 |
Figure S21. Get High-res Image Gene #56: 'DEL PEAK 34(18P11.31) MUTATION STATUS' versus Clinical Feature #8: 'HISTOLOGICAL.TYPE'
![](D56V8.png)
P value = 1.41e-10 (Fisher's exact test), Q value = 9.7e-08
Table S22. Gene #57: 'DEL PEAK 35(18Q12.2) MUTATION STATUS' versus Clinical Feature #8: 'HISTOLOGICAL.TYPE'
nPatients | COLON ADENOCARCINOMA | COLON MUCINOUS ADENOCARCINOMA |
---|---|---|
ALL | 364 | 55 |
DEL PEAK 35(18Q12.2) MUTATED | 241 | 11 |
DEL PEAK 35(18Q12.2) WILD-TYPE | 123 | 44 |
Figure S22. Get High-res Image Gene #57: 'DEL PEAK 35(18Q12.2) MUTATION STATUS' versus Clinical Feature #8: 'HISTOLOGICAL.TYPE'
![](D57V8.png)
P value = 0.000236 (Chi-square test), Q value = 0.16
Table S23. Gene #58: 'DEL PEAK 36(18Q21.2) MUTATION STATUS' versus Clinical Feature #3: 'NEOPLASM.DISEASESTAGE'
nPatients | STAGE I | STAGE IA | STAGE II | STAGE IIA | STAGE IIB | STAGE IIC | STAGE III | STAGE IIIA | STAGE IIIB | STAGE IIIC | STAGE IV | STAGE IVA | STAGE IVB |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ALL | 70 | 1 | 33 | 118 | 8 | 1 | 22 | 13 | 52 | 35 | 42 | 16 | 1 |
DEL PEAK 36(18Q21.2) MUTATED | 38 | 0 | 18 | 64 | 2 | 1 | 12 | 12 | 35 | 28 | 36 | 13 | 1 |
DEL PEAK 36(18Q21.2) WILD-TYPE | 32 | 1 | 15 | 54 | 6 | 0 | 10 | 1 | 17 | 7 | 6 | 3 | 0 |
Figure S23. Get High-res Image Gene #58: 'DEL PEAK 36(18Q21.2) MUTATION STATUS' versus Clinical Feature #3: 'NEOPLASM.DISEASESTAGE'
![](D58V3.png)
P value = 0.000108 (Fisher's exact test), Q value = 0.073
Table S24. Gene #58: 'DEL PEAK 36(18Q21.2) MUTATION STATUS' versus Clinical Feature #5: 'PATHOLOGY.N.STAGE'
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 246 | 100 | 74 |
DEL PEAK 36(18Q21.2) MUTATED | 135 | 72 | 58 |
DEL PEAK 36(18Q21.2) WILD-TYPE | 111 | 28 | 16 |
Figure S24. Get High-res Image Gene #58: 'DEL PEAK 36(18Q21.2) MUTATION STATUS' versus Clinical Feature #5: 'PATHOLOGY.N.STAGE'
![](D58V5.png)
P value = 1.95e-09 (Fisher's exact test), Q value = 1.3e-06
Table S25. Gene #58: 'DEL PEAK 36(18Q21.2) MUTATION STATUS' versus Clinical Feature #8: 'HISTOLOGICAL.TYPE'
nPatients | COLON ADENOCARCINOMA | COLON MUCINOUS ADENOCARCINOMA |
---|---|---|
ALL | 364 | 55 |
DEL PEAK 36(18Q21.2) MUTATED | 251 | 14 |
DEL PEAK 36(18Q21.2) WILD-TYPE | 113 | 41 |
Figure S25. Get High-res Image Gene #58: 'DEL PEAK 36(18Q21.2) MUTATION STATUS' versus Clinical Feature #8: 'HISTOLOGICAL.TYPE'
![](D58V8.png)
P value = 0.00022 (Fisher's exact test), Q value = 0.15
Table S26. Gene #59: 'DEL PEAK 37(18Q22.1) MUTATION STATUS' versus Clinical Feature #5: 'PATHOLOGY.N.STAGE'
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 246 | 100 | 74 |
DEL PEAK 37(18Q22.1) MUTATED | 136 | 71 | 58 |
DEL PEAK 37(18Q22.1) WILD-TYPE | 110 | 29 | 16 |
Figure S26. Get High-res Image Gene #59: 'DEL PEAK 37(18Q22.1) MUTATION STATUS' versus Clinical Feature #5: 'PATHOLOGY.N.STAGE'
![](D59V5.png)
P value = 1.97e-10 (Fisher's exact test), Q value = 1.4e-07
Table S27. Gene #59: 'DEL PEAK 37(18Q22.1) MUTATION STATUS' versus Clinical Feature #8: 'HISTOLOGICAL.TYPE'
nPatients | COLON ADENOCARCINOMA | COLON MUCINOUS ADENOCARCINOMA |
---|---|---|
ALL | 364 | 55 |
DEL PEAK 37(18Q22.1) MUTATED | 252 | 13 |
DEL PEAK 37(18Q22.1) WILD-TYPE | 112 | 42 |
Figure S27. Get High-res Image Gene #59: 'DEL PEAK 37(18Q22.1) MUTATION STATUS' versus Clinical Feature #8: 'HISTOLOGICAL.TYPE'
![](D59V8.png)
P value = 5.88e-05 (Fisher's exact test), Q value = 0.04
Table S28. Gene #60: 'DEL PEAK 38(19P13.3) MUTATION STATUS' versus Clinical Feature #5: 'PATHOLOGY.N.STAGE'
nPatients | N0 | N1 | N2 |
---|---|---|---|
ALL | 246 | 100 | 74 |
DEL PEAK 38(19P13.3) MUTATED | 21 | 15 | 22 |
DEL PEAK 38(19P13.3) WILD-TYPE | 225 | 85 | 52 |
Figure S28. Get High-res Image Gene #60: 'DEL PEAK 38(19P13.3) MUTATION STATUS' versus Clinical Feature #5: 'PATHOLOGY.N.STAGE'
![](D60V5.png)
-
Copy number data file = transformed.cor.cli.txt
-
Clinical data file = COAD-TP.clin.merged.picked.txt
-
Number of patients = 421
-
Number of significantly focal cnvs = 63
-
Number of selected clinical features = 11
-
Exclude genes that fewer than K tumors have mutations, K = 3
For survival clinical features, the Kaplan-Meier survival curves of tumors with and without gene mutations were plotted and the statistical significance P values were estimated by logrank test (Bland and Altman 2004) using the 'survdiff' function in R
For continuous numerical clinical features, two-tailed Student's t test with unequal variance (Lehmann and Romano 2005) was applied to compare the clinical values between tumors with and without gene mutations using 't.test' function in R
For multi-class clinical features (nominal or ordinal), Chi-square tests (Greenwood and Nikulin 1996) were used to estimate the P values using the 'chisq.test' function in R
For binary or multi-class clinical features (nominal or ordinal), two-tailed Fisher's exact tests (Fisher 1922) were used to estimate the P values using the 'fisher.test' function in R
For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.
In addition to the links below, the full results of the analysis summarized in this report can also be downloaded programmatically using firehose_get, or interactively from either the Broad GDAC website or TCGA Data Coordination Center Portal.